President and CEO Dr. Clifford Bleustein is the Global President and CEO of AposHealth. Prior to AposHealth, Dr. Bleustein was President and CEO of Computer Task Group (NASDAQ: CTG), where he managed >3400 people globally and >$340M in revenue across healthcare, technology services, energy, and financial services with operations in North America, Western Europe, and India. Dr. Bleustein went to CTG from Dell, where he had several roles, rising to become the Chief Medical Officer and Global Healthcare Solutions Leader with P&L responsibility for Healthcare & Life Sciences Solutions globally. Dr. Bleustein also had a successful period as a consultant at PwC, rising to Director with a diverse experience of projects including interim executive director of outpatient services, business strategy, international “biocluster” development, mergers & acquisitions, healthcare operations, physician alignment, governance, and resource optimization. He also has on-the-ground experience in the UK, Ireland, India, South Africa, and China, with assessments in the Middle East / Asia.

Dr.Bleustein graduated from the Medical College of Wisconsin and completed his internship at the New York Hospital Medical Center of Queens. He later completed his residency in urology at Montefiore Medical Center. He went on to private practice Urology and became a board-certified Urologist. He has an extensive roster of peer-reviewed published research and 2 patents. Dr. Bleustein earned a bachelor’s degree in science from the University of Wisconsin, Madison. He also received an executive master’s degree in business administration from NYU Stern School of Business, where he now teaches Healthcare Economics as an Adjunct Professor.

VP, Clinical Services Nina joined AposHealth in 2014. She holds a Doctorate in Physical Therapy and is an experienced Clinical Specialist in mobility, gait analysis, biomechanics, and neuroscience. Nina is known for her innovative approach and dedication to improving patient care. She has successfully advanced clinical operations by collaborating with research and business development teams, demonstrating her ability to integrate multidisciplinary efforts for optimal outcomes. Nina has developed and led priority training projects, including a comprehensive virtual training program that spans multiple departments. Her leadership was pivotal in overhauling the clinical training program to enhance telehealth capabilities, focusing on reducing delivery and contact time while optimizing clinical outcomes and operational costs. Her strategic thinking and commitment to excellence have driven forward-thinking clinical strategies and innovations, significantly contributing to the growth and success of the organization.

VP, Client Relationships Prior to joining AposHealth in 2019, Jed was the leader of voluntary benefits, leaves, and wellness at Deloitte, where he was responsible for leading a growing portfolio of employee benefit programs. His responsibilities included strategy, implementation, regulatory compliance, and ongoing management of 25 benefits and programs offered to all US employees through collaboration with internal and external stakeholders.

Throughout his 25-year career in benefits and wellness, Jed has held multiple positions with growing responsibilities within Deloitte and Johnson & Johnson Health Care Systems, Inc.

VP, Chief Compliance Officer Elizabeth Fitzgerald leads the compliance program at AposHealth, bringing over 17 years of diverse experience across both payor and provider aspects of healthcare operations, complemented by five years as a regulator. Her comprehensive and strategic approach ensures operational efficiency, compliance, and scalability.

Elizabeth earned her bachelor’s degree from Randolph-Macon Woman’s College (now Randolph College) and her Juris Doctor from Gonzaga University School of Law.

VP, Market Leader Veronica recently joined AposHealth after successfully leading the Client Success function within a mission-driven healthcare services company.

Veronica’s career experiences include roles within growth teams across retail, hospitality, wellness, healthcare, and employer benefit spaces. This broad set of experiences gives her a unique perspective to help solve challenges.

She received her undergraduate and graduate degrees in marketing from St. Joseph’s University.

SVP, Chief Operations Officer Fred has a proven track record of working with healthcare customers to drive value from their investments and driving transformational change. His success over the past 25 years is driven by his dedication to turning vision into reality. He has extensive experience with business development, financial management, budgeting, and organizational change management. Prior to joining AposHealth Fred worked in both Fortune 500 companies and start-ups. In his last position at Nordic Global Consulting, a large healthcare consulting firm, he delivered quality services for healthcare clients around the world. Fred is passionate about transforming healthcare and creating positive experiences for clients and patients.

SVP, Chief Financial Officer Mr. Ostro has over 15 years of progressive experience in audit and financial management of private and public companies and a proven record in providing high-quality financial management services to companies in various business cycles and sectors.
Previously, Mr. Ostro managed the valuation team of emerging market structured credit desk at Barclays Capital in London, UK, specializing in valuation and risk management of complex derivatives and structured financial products. Prior to that, he served as a Senior Associate in the audit division of PwC, Israel.
Mr. Ostro is a qualified certified public accountant in Israel and holds an MSc in Finance and Economics (with merit) from London School of Economics and a BSc in Economics and Accounting (with magna cum laude) from Tel-Aviv University.

GM, EVP, Chief Scientific & Innovation Officer Ganit joined AposHealth in 2006. She holds a master’s degree in life science, with a specialization in biomechanics and has more than 15 years’ experience in medical research including various clinical trial methodologies, scientific publications with over 35 publications in peer-review journals and substantial experience in scientific reviews including global clinical trends and guidelines, comparative analysis and more.
Since 2017, Ganit began laying the company’s foundations to collect and analyze big data in order to support post-marketing clinical activity and ongoing account management and improve patient care.